In Vitro Diagnostic
Table of Contents
examines the firm ’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. BioMerieux is a part of the Institut Merieux group. The industry player is engaged in providing in-vitro diagnostics for medical and industrial applications. The industry player designs, develops, manufactures and industry s systems used in clinical applications, such as for the diagnosi...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Trellis Bioscience, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, “Trellis Bioscience, Inc. - Product Pipeline Review - 2013” provides data on the Trellis ...
Summary Bio-Rad Laboratories, Inc. (Bio-Rad) is a healthcare company. It undertakes the development and manufacture of specialty chemicals for use in biochemical, pharmaceutical and other life science ...
Summary Xhale, Inc. (Xhale) is a medical device company. The company develops non invasive medical devices for the diagnostic market. Its products include pharmaceutical supply chain integrity, therapeutic ...
... molecular diagnostic strategy. Over the last several months, we have announced two significant opportunities to commercialize innovative molecular diagnostics tests. These types of opportunities allow us ...
... En jap n, las ventas se elevaron un 1%. En el segundo trimestre de 2013, roche ha comunicado los planes para integrar el rea de negocio applied science en molecular diagnostics y professional ...
Reportlinker.com © Copyright 2013. All rights reserved.